Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2013 (2013), Article ID 190962, 4 pages
http://dx.doi.org/10.1155/2013/190962
Case Report

Diabetic Myonecrosis: An Atypical Presentation

1Department of Endocrinology, 4th Floor, San Juan City Hospital, CMMS No. 79, P.O. Box 70344, San Juan, PR 00936-8344, USA
2Internal Medicine Department, San Juan City Hospital, CMMS No. 79, P.O. Box 70344, San Juan, PR 00936-8344, USA

Received 27 March 2013; Accepted 22 May 2013

Academic Editors: J. P. Frindik and W. V. Moore

Copyright © 2013 José Hernán Martínez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. E. Umpierrez, R. G. Stiles, J. Kleinbart, D. A. Krendel, and N. B. Watts, “Diabetic muscle infarction,” The American Journal of Medicine, vol. 101, no. 3, pp. 245–250, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Trujillo-Santos, “Diabetic muscle infarction: an underdiagnosed complication of long-standing diabetes,” Diabetes Care, vol. 26, no. 1, pp. 211–215, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. C. S. Chester and B. Q. Banker, “Focal infarction of muscle in diabetics,” Diabetes Care, vol. 9, no. 6, pp. 623–630, 1986. View at Google Scholar · View at Scopus
  4. E. K. Bjornskov, M. R. Carry, F. H. Katz, J. Lefkowitz, and S. P. Ringel, “Diabetic muscle infarction: a new perspective on pathogenesis and management,” Neuromuscular Disorders, vol. 5, no. 1, pp. 39–45, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. G. W. Palmer and T. P. Greco, “Diabetic thigh muscle infarction in association with antiphospholipid antibodies,” Seminars in Arthritis and Rheumatism, vol. 30, no. 4, pp. 272–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Gargiulo, R. Schiaffini, D. Bosco et al., “Diabetic microangiopathy: lupus anticoagulant dependent thrombotic tendency in type 1 (insulin-dependent) diabetes mellitus,” Diabetic Medicine, vol. 14, pp. 132–137, 1997. View at Google Scholar
  7. F. Galtier-Dereure, C. Biron, M. Vies, V. Bourgeois, J.-F. Schved, and J. Bringer, “Vascular complications of diabetes mellitus: what role for phospholipid-binding antibodies?” Lupus, vol. 7, no. 7, pp. 469–474, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Angervall and B. Stener, “Tumoriform focal muscular degeneration in two diabetic patients,” Diabetologia, vol. 1, no. 1, pp. 39–42, 1965. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Mukhopadhyay, R. Barai, C. A. Philips, J. Ghosh, and S. Saha, “An unusual case of myonecrosis,” Case Reports in Endocrinology, vol. 2011, Article ID 624020, 4 pages, 2011. View at Publisher · View at Google Scholar
  10. M. Frank and J. Finsterer, “Creatine kinase elevation, lactacidemia, and metabolic myopathy in adult patients with diabetes mellitus,” Endocrine Practice, vol. 18, no. 3, pp. 387–393, 2012. View at Google Scholar
  11. D. P. Chason, J. L. Fleckenstein, D. K. Burns, and G. Rojas, “Diabetic muscle infarction: radiologic evaluation,” Skeletal Radiology, vol. 25, no. 2, pp. 127–132, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kapur and R. J. McKendry, “Treatment and outcomes of diabetic muscle infarction,” Journal of Clinical Rheumatology, vol. 11, no. 1, pp. 8–12, 2005. View at Publisher · View at Google Scholar · View at Scopus